Code of Maine Rules
95 - INDEPENDENT AGENCIES
659 - THE MAINE VACCINE BOARD
Chapter 248 - LIST OF VACCINES TO BE PROVIDED BY THE UNIVERSAL CHILDHOOD IMMUNIZATION PROGRAM
Section 659-248-IV - Interim Modifications to Uniform Vaccine List
Current through 2024-13, March 27, 2024
The Board shall periodically review new vaccines and vaccines not on the authorized list and determine the feasibility of either adding or removing vaccines to or from the authorized uniform list in accordance with the criteria established in section II(B).
In the event the Board determines that revision of the authorized list of uniform vaccines is necessary to protect public health prior to revision of the authorized list through rulemaking, it may revise the authorized list on an interim basis, not to exceed 18 months, in accordance with the procedure established by subsection IV(C), provided that any interim revisions be included in the next scheduled Board rulemaking regarding uniform childhood vaccines.
The board may revise on an interim basis the authorized uniform list of childhood vaccines after conducting a public hearing in accordance with the requirements of 5°M.R.S.A. § 8052(2).
Any revision of the uniform childhood vaccine list is contingent upon the availability of adequate funding through the assessment mechanism established by 22 M.R.S.A. §1066(5).
IV Determining the total vaccine cost for the program § 1066(5)(A)(1)
A. The Department will estimate the total vaccine cost for the succeeding year based on age-cohort population estimates, the ACIP vaccination schedule, the list of vaccines determined by the board and projected immunization rates.
B. The Department will provide the Board with a projected vaccine cost for the succeeding year to be included in the assessment.
C. The Department will review vaccine usage projections and actual usage throughout the year to assure that the program remains within budget. The Department will provide quarterly reports to the board on vaccine usage and budget projections.
D. The Department will promptly notify the Board in the event of a vaccine shortage or other disruption of the vaccine supply that will affect the vaccine budget.
